FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry, namely to medicated products normalising cardiac function, particularly being perspective for treatment of coronary heart disease (CHD). Peptide of general formula CH3CO-Lys-Lys-Arg-Arg-NH2 is disclosed as an anti-ischemic and antihypoxic agent.
EFFECT: declared invention ensures apparent anti-ischemic, antihypoxic and adaptive action and is being available in medical practice.
1 cl, 3 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| CYCLIC PEPTIDES WITH ANTISTRESS EFFECT AND STRUCTURE SIMILAR TO CORTICOTROPIN | 2007 |
|
RU2330860C1 |
| PHARMACEUTICAL COMPOSITION SHOWING STRESS-PROTECTIVE ACTION, AND METHOD FOR PREVENTION AND TREATMENT OF FUNCTIONAL OR STRESS-INDUCED DISORDERS | 2009 |
|
RU2455310C2 |
| PHARMACEUTICAL COMPOSITION FROM GALLERIA MELLONELLA LARVAE AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2741801C2 |
| METHOD OF TREATING ENDOTHELIAL DYSFUNCTION IN DIABETES MELLITUS | 2019 |
|
RU2703567C1 |
| DRUG FOR GLYCOGEN SYNTHESIS STIMULATION IN CARDIAC MUSCLE AND METHOD FOR GLYCOGEN SYNTHESIS STIMULATION IN CARDIAC MUSCLE | 2010 |
|
RU2438679C1 |
| PEPTIDE COMPOUND RECOVERING FUNCTION OF MYOCARDIUM | 2004 |
|
RU2255756C1 |
| ANTIOXIDANT PREPARATION FOR TREATMENT AND PREVENTION OF CARDIAC PATHOLOGIES IN ANIMALS | 2023 |
|
RU2818764C1 |
| AGENT FOR DISEASES ASSOCIATED WITH STRESS-RELATED CONDITIONS IN DISEASES AND DISORDERS IN HUMAN AND ANIMALS, AND ALSO METHOD OF TREATING AND/OR PREVENTING WITH USING SUCH AGENT | 2009 |
|
RU2450823C2 |
| ANTIHYPOXIC AGENT | 2001 |
|
RU2213571C2 |
| METHOD OF TREATING AND PREVENTING MYOCARDIAL INFARCTION WITH PULMONARY PATHOLOGY | 2019 |
|
RU2718912C1 |
